abstract |
In the present invention, compositions and methods are provided for the treatment of diseases and / or disorders, including hyperglycemia and / or diabetes, and obesity in a subject. In particular, the present invention provides that the dry powder oral inhalation system comprises a dry powder composition of a GLP-1 analog comprising PEGylated-GLP-1 molecules and diketopiperazine. |